Low serum neurofilament light chain values identify optimal responders to dimethyl fumarate in multiple sclerosis treatment

Serum neurofilament light chains (sNfL) are biomarkers of disease activity in multiple sclerosis (MS), but their value to predict response to treatment, and their association with patient immunological profile, need to be further explored. We studied 80 relapsing–remitting MS patients initiating dim...

Descripción completa

Detalles Bibliográficos
Autores principales: Walo-Delgado, Paulette Esperanza, Sainz de la Maza, Susana, Villarrubia, Noelia, Monreal, Enric, Medina, Silvia, Espiño, Mercedes, Fernández-Velasco, José Ignacio, Rodríguez-Martín, Eulalia, Roldán, Ernesto, Lourido, Daniel, Muriel, Alfonso, Masjuan-Vallejo, Jaime, Costa-Frossard, Lucienne, Villar, Luisa María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085019/
https://www.ncbi.nlm.nih.gov/pubmed/33927255
http://dx.doi.org/10.1038/s41598-021-88624-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085019/
https://www.ncbi.nlm.nih.gov/pubmed/33927255
http://dx.doi.org/10.1038/s41598-021-88624-7

Ejemplares similares